We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-1.52%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$117M
AUM Growth
-$906K
Cap. Flow
+$1.73M
Cap. Flow %
1.48%
Top 10 Hldgs %
19.47%
Holding
135
New
4
Increased
57
Reduced
47
Closed
11

Top Buys

Rank Stock Value
1
BCE icon
BCE
BCE
+$1.28M
2
GSK icon
GSK
GSK
+$780K
3
BAX icon
Baxter International
BAX
+$763K
4
BNS icon
Scotiabank
BNS
+$598K
5
WBA
Walgreens Boots Alliance
WBA
+$577K

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.51%
2 Healthcare 14.72%
3 Financials 11.97%
4 Energy 9.44%
5 Technology 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$3.15M 2.69%
125,064
+2,288
+2% +$56.2K
UL icon
2
Unilever
UL
$140B
$2.86M 2.45%
60,685
+3,644
+6% +$180K
PG icon
3
Procter & Gamble
PG
$334B
$2.8M 2.39%
33,398
+63
+0.2% +$5.16K
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.26M 1.93%
16,358
-300
-2% -$40K
VIG icon
5
Vanguard Dividend Appreciation ETF
VIG
$113B
$2.07M 1.77%
26,948
-251
-0.9% -$19.5K
JNJ icon
6
Johnson & Johnson
JNJ
$646B
$2.05M 1.76%
19,261
+12
+0.1% +$1.25K
BAX icon
7
Baxter International
BAX
$13.5B
$2.02M 1.73%
51,797
+18,784
+57% +$763K
T icon
8
AT&T
T
$178B
$2.01M 1.72%
75,588
+1,228
+2% +$32.7K
BUD icon
9
AB InBev
BUD
$158B
$1.82M 1.56%
16,425
+550
+3% +$61.4K
CERN
10
DELISTED
Cerner Corp
CERN
$1.72M 1.47%
28,911
+5,259
+22% +$296K
BP icon
11
BP
BP
$109B
$1.66M 1.42%
46,165
+2,864
+7% +$113K
CFFN icon
12
Capitol Federal Financial
CFFN
$1.07B
$1.65M 1.41%
139,833
+7,007
+5% +$84.5K
MDLZ icon
13
Mondelez International
MDLZ
$79.6B
$1.64M 1.4%
47,938
-1,420
-3% -$51.7K
DEO icon
14
Diageo
DEO
$51.7B
$1.62M 1.38%
14,005
+100
+0.7% +$12.1K
GE icon
15
GE Aerospace
GE
$355B
$1.61M 1.38%
13,102
+799
+6% +$99.6K
MO icon
16
Altria Group
MO
$115B
$1.57M 1.34%
34,205
VZ icon
17
Verizon
VZ
$208B
$1.54M 1.32%
30,885
+5,440
+21% +$270K
ADP icon
18
Automatic Data Processing
ADP
$114B
$1.52M 1.3%
20,892
+257
+1% +$18.6K
GSK icon
19
GSK
GSK
$102B
$1.52M 1.3%
26,490
+12,720
+92% +$780K
BNS icon
20
Scotiabank
BNS
$113B
$1.52M 1.3%
26,156
+9,602
+58% +$598K
RAI
21
DELISTED
Reynolds American Inc
RAI
$1.51M 1.3%
51,340
CB
22
DELISTED
CHUBB CORPORATION
CB
$1.45M 1.24%
15,910
+150
+1% +$13.7K
MCD icon
23
McDonald's
MCD
$188B
$1.45M 1.24%
15,263
-3
-0% -$286
PM icon
24
Philip Morris
PM
$299B
$1.37M 1.17%
16,441
+75
+0.5% +$6.34K
OKS
25
DELISTED
Oneok Partners LP
OKS
$1.36M 1.17%
24,368
+3,004
+14% +$171K

Similar funds

Kavar Capital Partners Group's Q3 2014 Portfolio in Review

As of Q3 2014, Kavar Capital Partners Group held 135 positions worth $117M, down 0.77% from $118M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Kavar Capital Partners Group's Q3 2014 filing shows 4 new, 57 increased, 47 reduced and 11 closed positions. Its largest new stake was BCE: 28,600 shares worth $1.22M. The largest sale was Seadrill Limited Common Stock, an estimated $1.08M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Kavar Capital Partners Group's largest Q3 2014 buy was BCE: 28,600 shares worth $1.22M.
  • Kavar Capital Partners Group added most to GSK in Q3 2014, an estimated $780K increase.
  • Kavar Capital Partners Group's biggest Q3 2014 reduction was Kinder Morgan, cutting an estimated $271K.
  • Kavar Capital Partners Group fully exited Seadrill Limited Common Stock in Q3 2014, selling an estimated $1.08M.
  • Kavar Capital Partners Group's ten largest holdings make up 19% of its $117M portfolio in Q3 2014.
  • Kavar Capital Partners Group opened 4 new positions and closed 11 in Q3 2014.
  • Kavar Capital Partners Group's portfolio value fell 0.77% quarter-over-quarter to $117M.

Based on Kavar Capital Partners Group's 13F filing for Q3 2014, filed 25 Jan 2019.